{{PBB|geneid=51561}}
'''Interleukin-23 subunit alpha''' is a [[protein]] that in humans is encoded by the ''IL23A'' [[gene]].<ref name="pmid11114383">{{cite journal | author = Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA | title = Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 | journal = Immunity | volume = 13 | issue = 5 | pages = 715–25 | year = 2001 | month = Jan | pmid = 11114383 | pmc =  | doi =10.1016/S1074-7613(00)00070-4  }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: IL23A interleukin 23, alpha subunit p19| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51561| accessdate = }}</ref> IL-23 is produced by [[dendritic cells]] and [[macrophages]]. <!--Moreover, IL-23 is stimulated by Danger Signals, including cell debris, and directs [[memory T cell]]s to [[Th17]] response. - IT IS UNCLEAR WHAT THIS MEANS OR WHY THIS DETAIL IS STATED HERE-->

<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title = 
| summary_text = This gene encodes the p19 subunit of the heterodimeric cytokine interleukin 23 (IL23). IL23 is composed of this protein and the p40 subunit of interleukin 12 ([[IL12B]]). The receptor of IL23 is formed by the beta 1 subunit of IL12 (IL12RB1) and an IL23 specific subunit, IL23R. Both IL23 and IL12 can activate the transcription activator STAT4, and stimulate the production of interferon-gamma (IFNG). In contrast to IL12, which acts mainly on naive CD4(+) T cells, IL23 preferentially acts on memory CD4(+) T cells.<ref name="entrez" />
}}

Interleukin-23 (IL-23) is a [[heterodimer]]ic [[cytokine]] consisting of two subunits: p40, which is also a component of the [[interleukin 12|IL-12]] cytokine, p19, which is considered the IL-23 alpha subunit. In other words, IL-23 is a dimer of [[Interleukin-12 subunit beta|p40]]-S-S-[[p19]].

IL-23 is an important part of the [[inflammation|inflammatory response]] against [[infection]]. It promotes upregulation of the matrix [[metalloprotease]] [[MMP9]], increases [[angiogenesis]] and reduces [[cytotoxic T cell|CD8+ T-cell]] infiltration.  In conjunction with [[interleukin-6|IL-6]] and [[Transforming growth factor|TGF]]-β1, IL-23 stimulates naive [[helper T cells|CD4+ T cells]] to differentiate into a novel subset of cells called [[T helper 17 cell|Th17 cells]], which are distinct from the classical Th1 and Th2 cells.  Th17 cells produce [[interleukin 17|IL-17]], a proinflammatory cytokine that enhances T cell priming and stimulates the production of other proinflammatory molecules such as [[interleukin 1|IL-1]], [[interleukin 6|IL-6]], [[TNF-alpha]], [[nitric oxide synthase|NOS-2]], and [[chemokines]] resulting in inflammation.

Knockout mice deficient in either p40 or p19, or in either subunit of the IL-23 receptor (IL-23R and IL12R-β1) develop less severe symptoms of multiple sclerosis and inflammatory bowel disease highlighting the importance of IL-23 in the inflammatory pathway.<ref name="pmid16688182">{{cite journal | author = Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M | title = IL-23 promotes tumour incidence and growth | journal = Nature | volume = 442 | issue = 7101 | pages = 461–5 | year = 2006 | pmid = 16688182 | doi = 10.1038/nature04808 }}</ref><ref name="pmid17010592">{{cite journal | author = Kikly K, Liu L, Na S, Sedgwick JD | title = The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation | journal = Curr. Opin. Immunol. | volume = 18 | issue = 6 | pages = 670–5 | year = 2006 | pmid = 17010592 | doi = 10.1016/j.coi.2006.09.008 }}</ref>


==Interactions==
Interleukin 23 has been shown to [[Protein-protein interaction|interact]] with [[Interleukin-12 subunit beta]].<ref name=pmid11114383>{{cite journal |last=Oppmann |first=B |authorlink= |coauthors=Lesley R, Blom B, Timans J C, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams J S, Moore K W, Rennick D, de Waal-Malefyt R, Hannum C, Bazan J F, Kastelein R A |year=[[2000]]|month=Nov. |title=Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 |journal=Immunity |volume=13 |issue=5 |pages=715–25 |publisher= |location = UNITED STATES| issn = 1074-7613| pmid = 11114383 | bibcode = | oclc =| id = | url = | language = | accessdate = | laysummary = | laysource = | laydate = | quote = |doi=10.1016/S1074-7613(00)00070-4 }}</ref>

==See also==
* [[CNTO 1275]], an experimental therapeutic anti-IL-23 antibody

==References==
{{reflist}}

==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading 
| citations = 
*{{cite journal  | author=Lankford CS, Frucht DM |title=A unique role for IL-23 in promoting cellular immunity |journal=J. Leukoc. Biol. |volume=73 |issue= 1 |pages= 49–56 |year= 2003 |pmid= 12525561 |doi=10.1189/jlb.0602326  }}
*{{cite journal  | author=van de Vosse E, Lichtenauer-Kaligis EG, van Dissel JT, Ottenhoff TH |title=Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function |journal=Immunogenetics |volume=54 |issue= 12 |pages= 817–29 |year= 2003 |pmid= 12671732 |doi= 10.1007/s00251-002-0534-9 }}
*{{cite journal  | author=Kreymborg K, Böhlmann U, Becher B |title=IL-23: changing the verdict on IL-12 function in inflammation and autoimmunity |journal=Expert Opin. Ther. Targets |volume=9 |issue= 6 |pages= 1123–36 |year= 2006 |pmid= 16300465 |doi= 10.1517/14728222.9.6.1123 }}
*{{cite journal  | author=Peluso I, Pallone F, Monteleone G |title=Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication |journal=World J. Gastroenterol. |volume=12 |issue= 35 |pages= 5606–10 |year= 2006 |pmid= 17007011 |doi=  }}
*{{cite journal  | author=Prashar Y, Weissman SM |title=Analysis of differential gene expression by display of 3' end restriction fragments of cDNAs |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=93 |issue= 2 |pages= 659–63 |year= 1996 |pmid= 8570611 |doi=10.1073/pnas.93.2.659  | pmc=40108  }}
*{{cite journal  | author=Wiekowski MT |title=Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death |journal=J. Immunol. |volume=166 |issue= 12 |pages= 7563–70 |year= 2001 |pmid= 11390512 |doi=  | author-separator=,  | author2=Leach MW  | author3=Evans EW  | display-authors=3  | last4=Sullivan  | first4=L  | last5=Chen  | first5=SC  | last6=Vassileva  | first6=G  | last7=Bazan  | first7=JF  | last8=Gorman  | first8=DM  | last9=Kastelein  | first9=RA  }}
*{{cite journal  | author=Parham C |title=A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R |journal=J. Immunol. |volume=168 |issue= 11 |pages= 5699–708 |year= 2002 |pmid= 12023369 |doi=  | author-separator=,  | author2=Chirica M  | author3=Timans J  | display-authors=3  | last4=Vaisberg  | first4=E  | last5=Travis  | first5=M  | last6=Cheung  | first6=J  | last7=Pflanz  | first7=S  | last8=Zhang  | first8=R  | last9=Singh  | first9=KP  }}
*{{cite journal  | author=Broberg EK |title=Herpes simplex virus type 1 infection induces upregulation of interleukin-23 (p19) mRNA expression in trigeminal ganglia of BALB/c mice |journal=J. Interferon Cytokine Res. |volume=22 |issue= 6 |pages= 641–51 |year= 2003 |pmid= 12162874 |doi= 10.1089/10799900260100123  | author-separator=,  | author2=Setälä N  | author3=Erälinna JP  | display-authors=3  | last4=Salmi  | first4=Aimo A.  | last5=Röyttä  | first5=Matias  | last6=Hukkanen  | first6=Veijo }}
*{{cite journal  | author=Pirhonen J, Matikainen S, Julkunen I |title=Regulation of virus-induced IL-12 and IL-23 expression in human macrophages |journal=J. Immunol. |volume=169 |issue= 10 |pages= 5673–8 |year= 2003 |pmid= 12421946 |doi=  }}
*{{cite journal  | author=Strausberg RL |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899  | pmc=139241  | author-separator=,  | author2=Feingold EA  | author3=Grouse LH  | display-authors=3  | last4=Derge  | first4=JG  | last5=Klausner  | first5=RD  | last6=Collins  | first6=FS  | last7=Wagner  | first7=L  | last8=Shenmen  | first8=CM  | last9=Schuler  | first9=GD }}
*{{cite journal  | author=Lo CH |title=Antitumor and antimetastatic activity of IL-23 |journal=J. Immunol. |volume=171 |issue= 2 |pages= 600–7 |year= 2003 |pmid= 12847224 |doi=  | author-separator=,  | author2=Lee SC  | author3=Wu PY  | display-authors=3  | last4=Pan  | first4=WY  | last5=Su  | first5=J  | last6=Cheng  | first6=CW  | last7=Roffler  | first7=SR  | last8=Chiang  | first8=BL  | last9=Lee  | first9=CN  }}
*{{cite journal  | author=Clark HF |title=The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment |journal=Genome Res. |volume=13 |issue= 10 |pages= 2265–70 |year= 2003 |pmid= 12975309 |doi= 10.1101/gr.1293003  | pmc=403697  | author-separator=,  | author2=Gurney AL  | author3=Abaya E  | display-authors=3  | last4=Baker  | first4=K  | last5=Baldwin  | first5=D  | last6=Brush  | first6=J  | last7=Chen  | first7=J  | last8=Chow  | first8=B  | last9=Chui  | first9=C }}
*{{cite journal  | author=Lee E |title=Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris |journal=J. Exp. Med. |volume=199 |issue= 1 |pages= 125–30 |year= 2004 |pmid= 14707118 |doi= 10.1084/jem.20030451  | pmc=1887731  | author-separator=,  | author2=Trepicchio WL  | author3=Oestreicher JL  | display-authors=3  | last4=Pittman  | first4=D  | last5=Wang  | first5=F  | last6=Chamian  | first6=F  | last7=Dhodapkar  | first7=M  | last8=Krueger  | first8=JG }}
*{{cite journal  | author=Verreck FA |title=Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=101 |issue= 13 |pages= 4560–5 |year= 2004 |pmid= 15070757 |doi= 10.1073/pnas.0400983101  | pmc=384786  | author-separator=,  | author2=de Boer T  | author3=Langenberg DM  | display-authors=3  | last4=Hoeve  | first4=MA  | last5=Kramer  | first5=M  | last6=Vaisberg  | first6=E  | last7=Kastelein  | first7=R  | last8=Kolk  | first8=A  | last9=De Waal-Malefyt  | first9=R }}
*{{cite journal  | author=Smits HH |title=Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development |journal=Eur. J. Immunol. |volume=34 |issue= 5 |pages= 1371–80 |year= 2004 |pmid= 15114670 |doi= 10.1002/eji.200324815  | author-separator=,  | author2=van Beelen AJ  | author3=Hessle C  | display-authors=3  | last4=Westland  | first4=Robert  | last5=De Jong  | first5=Esther  | last6=Soeteman  | first6=Eelco  | last7=Wold  | first7=Agnes  | last8=Wierenga  | first8=Eddy?A.  | last9=Kapsenberg  | first9=Martien?L. }}
*{{cite journal  | author=Schnurr M |title=Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway |journal=Blood |volume=105 |issue= 4 |pages= 1582–9 |year= 2005 |pmid= 15486065 |doi= 10.1182/blood-2004-05-1718  | author-separator=,  | author2=Toy T  | author3=Shin A  | display-authors=3  | last4=Wagner  | first4=M  | last5=Cebon  | first5=J  | last6=Maraskovsky  | first6=E }}
*{{cite journal  | author=Gerhard DS |title=The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504  | pmc=528928  | author-separator=,  | author2=Wagner L  | author3=Feingold EA  | display-authors=3  | last4=Shenmen  | first4=CM  | last5=Grouse  | first5=LH  | last6=Schuler  | first6=G  | last7=Klein  | first7=SL  | last8=Old  | first8=S  | last9=Rasooly  | first9=R }}
}}
{{refend}}

{{interleukins}}

[[Category:Cytokines]]

<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes 
| require_manual_inspection = no 
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}